Literature DB >> 18854945

p53 isoforms - a conspiracy to kidnap p53 tumor suppressor activity?

V Marcel1, P Hainaut.   

Abstract

For 25 years, the p53 tumor suppressor protein was considered the only protein expressed by the (TP53) gene. However, in several studies the existence of p53 alternative transcripts in mouse and human cells has been documented, while their expression patterns and functions remained a mystery. Since 2002, several groups have identified and described the existence of up to 10 p53 isoforms and have demonstrated their roles in modulation of p53 suppressive activity. It is now clear that the patterns of p53 expression are much more complex than previously recognized and that these isoforms have the potential to act either synergistically or antagonistically, depending on their structure and mechanism of production. This review focuses on the different ways to produce p53 isoforms, on their specific properties, on their effect on p53 suppressive activity as well as on their implication in a new potential mechanism involved in p53 deregulation in cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18854945     DOI: 10.1007/s00018-008-8336-3

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  29 in total

1.  Length and secondary structure of the 5' non-coding regions of mouse p53 mRNA transcripts - mouse as a model organism for p53 gene expression studies.

Authors:  Joanna Szpotkowska; Agata Swiatkowska; Jerzy Ciesiołka
Journal:  RNA Biol       Date:  2018-12-20       Impact factor: 4.652

Review 2.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

3.  CD147 and Ki-67 overexpression confers poor prognosis in squamous cell carcinoma of oral tongue: a tissue microarray study.

Authors:  Yau-Hua Yu; Jose Morales; Lei Feng; J Jack Lee; Adel K El-Naggar; Nadarajah Vigneswaran
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol       Date:  2015-01-07

4.  p53 Isoforms: An Intracellular Microprocessor?

Authors:  Marie P Khoury; Jean-Christophe Bourdon
Journal:  Genes Cancer       Date:  2011-04

5.  Role of p63 in Development, Tumorigenesis and Cancer Progression.

Authors:  Johann Bergholz; Zhi-Xiong Xiao
Journal:  Cancer Microenviron       Date:  2012-07-31

Review 6.  Protein-protein interaction networks: how can a hub protein bind so many different partners?

Authors:  Chung-Jung Tsai; Buyong Ma; Ruth Nussinov
Journal:  Trends Biochem Sci       Date:  2009-12       Impact factor: 13.807

Review 7.  Overexpression of p53 protein in human tumors.

Authors:  Keiji Inoue; Atsushi Kurabayashi; Taro Shuin; Yuji Ohtsuki; Mutsuo Furihata
Journal:  Med Mol Morphol       Date:  2012-09-22       Impact factor: 2.309

Review 8.  Aberrant splicing of the DMP1-ARF-MDM2-p53 pathway in cancer.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Int J Cancer       Date:  2016-02-08       Impact factor: 7.396

Review 9.  Biological functions of p53 isoforms through evolution: lessons from animal and cellular models.

Authors:  V Marcel; M-L Dichtel-Danjoy; C Sagne; H Hafsi; D Ma; S Ortiz-Cuaran; M Olivier; J Hall; B Mollereau; P Hainaut; J-C Bourdon
Journal:  Cell Death Differ       Date:  2011-09-23       Impact factor: 15.828

10.  Diverse p63 and p73 isoforms regulate Δ133p53 expression through modulation of the internal TP53 promoter activity.

Authors:  V Marcel; I Petit; F Murray-Zmijewski; T Goullet de Rugy; K Fernandes; V Meuray; A Diot; D P Lane; D Aberdam; J-C Bourdon
Journal:  Cell Death Differ       Date:  2011-11-11       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.